HOOKIPA PHARMA INC. Net Change in Cash
HOOKIPA PHARMA INC. reported Net Change in Cash of -$3.86 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-05-11
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$3.86M, a 105.13% decline year-over-year.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $75.20M.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$14.63M.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$8.61M, a 137.93% decline year-over-year.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $47.26M.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$78.83M, a 348.60% decline from fiscal 2020.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $31.71M, a 51.97% decline from fiscal 2019.
- HOOKIPA PHARMA INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $66.02M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$3.86M 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $47.26M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $34.91M 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $52.25M 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $75.20M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$78.83M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | -$60.04M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$39.90M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$14.63M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $31.71M 10-K · filed 2023-03-15 | |||
| 2020-09-30 | -$31.56M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$20.35M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$8.61M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $66.02M 10-K · filed 2022-03-24 | |||
| 2019-09-30 | $76.74M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $87.12M 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | $22.70M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | -$10.28M 10-K · filed 2021-03-18 | |||
| 2018-09-30 | -$3.65M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $3.80M 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $45.68M 10-K · filed 2020-03-19 |